XML 39 R17.htm IDEA: XBRL DOCUMENT
v3.25.3

Joint Ventures, VIEs and Other Investments | 12 Months Ended
--- | ---
Sep. 26, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Joint Ventures, VIEs and Other Investments | Joint Ventures, VIEs and Other Investments For consolidated joint ventures, the entire amount of the revenue recognized for services performed and the costs associated with these services, including the services provided by the other joint venture partners, are included in the Company's results of operations. Likewise, the entire amount of each of the assets and liabilities are included in the Company’s consolidated balance sheet. There are no consolidated VIEs that have debt or credit facilities. Summary financial information of consolidated VIEs is as follows (in millions):
| September 26, 2025 |  | September 27, 2024
Current assets | $ | 163.4 |  |  | $ | 161.9 |
Total assets | $ | 163.4 |  |  | $ | 161.9 |
Current liabilities | $ | 144.7 |  |  | $ | 122.7 |
Total liabilities | $ | 144.7 |  |  | $ | 122.7 |
| For the Years Ended
| September 26, 2025 |  | September 27, 2024 |  | September 29, 2023
Revenue | $ | 401.9 |  |  | $ | 472.0 |  |  | $ | 485.5 |
Direct cost of contracts | (392.4) |  |  | (431.2) |  |  | (443.1) |
Gross profit | $ | 9.5 |  |  | $ | 40.8 |  |  | $ | 42.4 |
Net earnings | $ | 9.5 |  |  | $ | 40.8 |  |  | $ | 42.4 |
Unconsolidated joint ventures are accounted for under the equity method or proportionate consolidation. Proportionate consolidation is used for joint ventures that include unincorporated legal entities and activities of the joint venture are construction-related. For those joint ventures accounted for under proportionate consolidation, only the Company’s pro rata share of assets, liabilities, revenue, and costs are included in the Company’s balance sheet and results of operations. For the proportionate consolidated VIEs, the carrying value of assets and liabilities was $143.9 million and $131.9 million as of September 26, 2025, respectively, and $138.8 million and $138.0 million as of September 27, 2024, respectively. For those joint ventures accounted for under the equity method, the Company's investment balances for the joint venture is included in other noncurrent assets: miscellaneous on the balance sheet and the Company’s pro rata share of net income is included in revenue. In limited cases, there are basis differences between the equity in the joint venture and Jacobs' investment created when Jacobs purchased their share of the joint venture. These basis differences are amortized based on an internal allocation to underlying net assets, excluding allocations to goodwill. Our investments in equity method joint ventures on the Consolidated Balance Sheets as of September 26, 2025 and September 27, 2024 were a net asset of $36.3 million and $36.6 million, respectively. During the years ended September 26, 2025, September 27, 2024, and September 29, 2023, we recognized income from equity method joint ventures of $8.8 million, $11.9 million, and $3.1 million, respectively. Accounts receivable from unconsolidated joint ventures accounted for under the equity method is $13.6 million and $12.3 million as of September 26, 2025 and September 27, 2024, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 323 -Publisher FASB -URI https://asc.fasb.org/323/tableOfContent + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration